Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Dermatologic 1CNS 1

Conditions

Breast Neoplasms 57Pancreatic Neoplasms 39Carcinoma, Non-Small-Cell Lung 29Triple Negative Breast Neoplasms 20Neoplasms 17Neoplasm Metastasis 11Lung Neoplasms 10Squamous Cell Carcinoma of Head and Neck 9Ovarian Neoplasms 8Melanoma 7Head and Neck Neoplasms 6Breast Neoplasms, Male 6Adenocarcinoma 6Urinary Bladder Neoplasms 5Inflammatory Breast Neoplasms 5Carcinoma 5Sarcoma 4Parkinson Disease 4, Autosomal Dominant Lewy Body 4Pancreatic Diseases 4Fallopian Tube Neoplasms 4Cholangiocarcinoma 4Carcinoma, Ovarian Epithelial 4Stomach Neoplasms 3Small Cell Lung Carcinoma 3Pancreatic Adenocarcinoma 3Esophageal Neoplasms 3Endocrine System Diseases 3Endocrine Gland Neoplasms 3Digestive System Neoplasms 3Digestive System Diseases 3

Interventions

Ifosfamide 3Doxorubicin 3pazopanib 2Sunitinib 2Radiotherapy, Conformal 2Radiotherapy 2temsirolimus 1saracatinib 1romidepsin 1indolepropanol phosphate 1etoposide phosphate 1cixutumumab 1Watchful Waiting 1Vincristine 1Surgical Procedures, Operative 1Sirolimus 1Razoxane 1Radiotherapy, Intensity-Modulated 1Radiation 1Polymerase Chain Reaction 1Observation 1Neoadjuvant Therapy 1Mesna 1HhAntag691 1Granulocyte Colony-Stimulating Factor 1Gene Expression Profiling 1Gemcitabine 1Filgrastim 1Etoposide 1Dexrazoxane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Fibrosarcoma × Albumin-Bound Paclitaxel × Clear all
NCT01962103 2019-12-27

Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors

Celgene

Phase 1/2 Completed
107 enrolled 42 charts
CNSDermatologicSarcoma

Fibrosarcoma, Melanoma, Neoplasms, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Dermatofibrosarcoma, Histiocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡